Intravitreal Infliximab for the Treatment of Proliferative Vitreoretinopathy (FIXER)
Ophthalmology Retina · 2024
DOI: 10.1016/j.oret.2024.05.016 ↗Kurz gefasst
Klinische Studie (Phase II) in der Zeitschrift Ophthalmology Retina, 2024. Verfasst von Ahmed M Younes und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ophthalmology, Faculty of Medicine, Cairo University, Cairo, Egypt. Hauptthemen laut MEDLINE: Infliximab, Intravitreal Injections, Retinal Detachment, Vitreoretinopathy, Proliferative. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 41 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Ophthalmology, Faculty of Medicine, Cairo University, Cairo, Egypt.
- Department of Ophthalmology, Faculty of Medicine, Cairo University, Cairo, Egypt. Electronic address: ayman_elnahri@hotmail.com.
Zitieren
APA
Younes, A. M., Hamza, H. S., Omar, H. A., Abdel-Kader, A. A., Abdelbaki, A. M., & Elnahry, A. G. (2024). Intravitreal Infliximab for the Treatment of Proliferative Vitreoretinopathy (FIXER). Ophthalmology Retina. https://doi.org/10.1016/j.oret.2024.05.016
Vancouver
Younes AM, Hamza HS, Omar HA, Abdel-Kader AA, Abdelbaki AM, Elnahry AG. Intravitreal Infliximab for the Treatment of Proliferative Vitreoretinopathy (FIXER). Ophthalmology Retina. 2024. doi:10.1016/j.oret.2024.05.016
BibTeX
@article{Younes2024,
author = {Younes, Ahmed M and Hamza, Hany S and Omar, Hisham A and Abdel-Kader, Ahmed A and Abdelbaki, Ahmed M and Elnahry, Ayman G},
title = {Intravitreal Infliximab for the Treatment of Proliferative Vitreoretinopathy (FIXER)},
journal = {Ophthalmology Retina},
year = {2024},
doi = {10.1016/j.oret.2024.05.016}
}
EUVIMED